SCHEMBL7400563

SCHEMBL7400563

N=C(N)c1ccc2[nH]c(Cc3nc4c(OCCN5C(=O)C6CCCCC6C5=O)cc(F)cc4[nH]3)nc2c1

nearest known ligand 0.53

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
F10 P00742 13/20 0.53
TPSAB1 Q15661 3/20 0.40
F2 P00734 3/20 0.40
PRSS1 P07477 2/20 0.40
PLG P00747 1/20 0.40
PLAU P00749 1/20 0.40
PRSS2 P07478 1/20 0.40
PRSS3 P35030 1/20 0.40
TPSD1 Q9BZJ3 1/20 0.39
TPSG1 Q9NRR2 1/20 0.39
F7 P08709 2/20 0.39
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7408199 0.87 F10 (0.55) F10TPSAB1F2PRSS1PLG
SCHEMBL7516744 0.85 F10 (0.58) F10TPSAB1F2PRSS1PLG
SCHEMBL7405267 0.84 F10 (0.53) F10TPSAB1F2PRSS1PLG
SCHEMBL7402644 0.83 F10 (0.54) F10TPSAB1F2PRSS1PLG
SCHEMBL7407783 0.83 F10 (0.53) F10TPSAB1F2PRSS1PLG
SCHEMBL7407515 0.83 F10 (0.56) F10TPSAB1F2PRSS1PLG
SCHEMBL7409477 0.81 F10 (0.68) F10TPSAB1F2PRSS1PLG
SCHEMBL7411875 0.80 F10 (0.56) F10TPSAB1F2PRSS1PLG
SCHEMBL7407599 0.80 F10 (0.56) F10TPSAB1F2PRSS1PLG
SCHEMBL7404722 0.80 F10 (0.56) F10TPSAB1F2PRSS1PLG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1999026932-A1 BY AMIDINO GROUP SUBSTITUTED HETEROCYCLIC DERIVATIVES AND THEIR USE AS ANTICOAGULANTS AXYS PHARMACEUTICALS, INC. (US) 1999-06-03 WO claimed
WO-1999026932-A1 BY AMIDINO GROUP SUBSTITUTED HETEROCYCLIC DERIVATIVES AND THEIR USE AS ANTICOAGULANTS AXYS PHARMACEUTICALS, INC. (US) 1999-06-03 WO disclosed